Within Hours, Surgical Implant Lets Paralyzed Patients Walk

Multiple clinical trial participants who have severe spinal injuries were able to stand, walk, and perform specific activities after just one day of using an implant surgically embedded in their spines.

black and white image of young man in sunglasses with trees in background
| 2 min read
Left: Two men wearing coats and hats who are standing side-by-side on a sidewalk walk towards the camera with the assistance of walkers. Right: artist’s rendering of an oval-shaped medical implant dotted with electrodes that has wires protruding from one end.
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

When Michel Rocatti completely severed his spinal cord in a 2017 motorcycle accident, he permanently lost all sensation in and control over his legs. For years, Rocatti was unable to walk—until an experimental implant was surgically embedded into his spine, re-completing the broken biological circuit between his spinal cord and the severed nerves, The Guardian reports.

When prompted, the device sends activity-specific pulses of electricity to various nerves that were cut off from the central nervous system, allowing the Rocatti and other paralyzed people to send the appropriate stimulation and instructions to their legs. Rocatti and the other two participants in an ongoing clinical trial were able to stand, walk, use bicycle pedals, and kick their legs in a swimming pool within hours of having the flexible, multi-electrode device embedded into their spines, according to research published Monday (February 7) in Nature Medicine. The device and software, developed by researchers ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • black and white image of young man in sunglasses with trees in background

    Dan Robitzski

    Dan is a News Editor at The Scientist. He writes and edits for the news desk and oversees the “The Literature” and “Modus Operandi” sections of the monthly TS Digest and quarterly print magazine. He has a background in neuroscience and earned his master's in science journalism at New York University.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours